The Impact of Chronic Oral Beta-Blocker Intake on Intravenous Bolus Landiolol Response in Hospitalized Intensive Care Patients with Sudden-Onset Supraventricular Tachycardia-A Post Hoc Analysis of a Cross-Sectional Trial

• Autori principali: Felix Eibensteiner (Autore), Emmilie Mosor (Autore), Daniel Tihanyi (Autore), Sonja Anders (Autore), Andrea Kornfehl (Autore), Marco Neymayer (Autore), Julia Oppenauer (Autore), Christoph Veigl (Autore), Valentin Al Jalali (Autore), Hans Domanovits (Autore), Patrick Sulzgruber (Autore), Sebastian Schnaubelt (Autore)
• Natura: Libro
• Pubblicazione: MDPI AG, 2024-06-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

<b>Background:</b> Landiolol, a highly cardioselective agent with a short half-life (2.4-4 min), is commonly used as a perfusor or bolus application to treat tachycardic arrhythmia. Some small studies suggest that prior oral β-blocker use results in a less effective response to intraveno...